Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe

INTRODUCTION: The broad and sustained efficacy of apremilast for psoriasis has been demonstrated in randomized and real-world observational studies. Data from Central and Eastern Europe (CEE) are lacking. Moreover, apremilast use in this region is limited by country-specific reimbursement criteria....

Descripción completa

Detalles Bibliográficos
Autores principales: Cetkovská, Petra, Dediol, Iva, Šola, Marija, Kojanová, Martina, Trčko, Katarina, Čarija, Antoanela, Čeović, Romana, Ledić-Drvar, Daniela, Kaštelan, Marija, Hrabar, Andina, Missoup, Myriam Cordey, Mamun, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979124/
https://www.ncbi.nlm.nih.gov/pubmed/36862361
http://dx.doi.org/10.1007/s12325-023-02468-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979124/
https://www.ncbi.nlm.nih.gov/pubmed/36862361
http://dx.doi.org/10.1007/s12325-023-02468-3

Ejemplares similares